AMRX
Price
$9.70
Change
+$0.08 (+0.83%)
Updated
Sep 8, 12:35 PM (EDT)
Capitalization
3.02B
60 days until earnings call
PRFX
Price
$1.42
Change
-$0.00 (-0.00%)
Updated
Sep 8, 01:05 PM (EDT)
Capitalization
2.86M
66 days until earnings call
Interact to see
Advertisement

AMRX vs PRFX

Header iconAMRX vs PRFX Comparison
Open Charts AMRX vs PRFXBanner chart's image
Amneal Pharmaceuticals
Price$9.70
Change+$0.08 (+0.83%)
Volume$587
Capitalization3.02B
PainReform
Price$1.42
Change-$0.00 (-0.00%)
Volume$133
Capitalization2.86M
AMRX vs PRFX Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. PRFX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and PRFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (AMRX: $9.62 vs. PRFX: $1.42)
Brand notoriety: AMRX and PRFX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMRX: 86% vs. PRFX: 12%
Market capitalization -- AMRX: $3.02B vs. PRFX: $2.86M
AMRX [@Pharmaceuticals: Generic] is valued at $3.02B. PRFX’s [@Pharmaceuticals: Generic] market capitalization is $2.86M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while PRFX’s TA Score has 3 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 4 bearish.
  • PRFX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than PRFX.

Price Growth

AMRX (@Pharmaceuticals: Generic) experienced а +0.63% price change this week, while PRFX (@Pharmaceuticals: Generic) price change was -2.07% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.10%. For the same industry, the average monthly price growth was +9.00%, and the average quarterly price growth was +87.12%.

Reported Earning Dates

AMRX is expected to report earnings on Nov 07, 2025.

PRFX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($3.02B) has a higher market cap than PRFX($2.86M). AMRX YTD gains are higher at: 21.465 vs. PRFX (-57.675). PRFX has less debt than AMRX: PRFX (59K) vs AMRX (2.58B).
AMRXPRFXAMRX / PRFX
Capitalization3.02B2.86M105,666%
EBITDA584MN/A-
Gain YTD21.465-57.675-37%
P/E Ratio962.00N/A-
Revenue2.85BN/A-
Total Cash71.5MN/A-
Total Debt2.58B59K4,376,271%
FUNDAMENTALS RATINGS
AMRX: Fundamental Ratings
AMRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMRXPRFX
RSI
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 5 days ago
87%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGX1.910.13
+7.30%
Metagenomi
HII271.131.15
+0.43%
Huntington Ingalls Industries
PAR48.300.18
+0.37%
PAR Technology Corp
SD11.44-0.37
-3.13%
SandRidge Energy
UK1.07-0.05
-4.05%
Ucommune International Ltd

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.73%
PAHC - AMRX
46%
Loosely correlated
+0.97%
VTRS - AMRX
43%
Loosely correlated
+1.65%
TEVA - AMRX
40%
Loosely correlated
+2.54%
COLL - AMRX
39%
Loosely correlated
-2.32%
ALKS - AMRX
38%
Loosely correlated
+3.53%
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and BHC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and BHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
-12.62%
BHC - PRFX
26%
Poorly correlated
+1.94%
AMRX - PRFX
24%
Poorly correlated
+0.73%
EVOK - PRFX
24%
Poorly correlated
-1.51%
ZTS - PRFX
22%
Poorly correlated
+0.08%
PBH - PRFX
21%
Poorly correlated
-2.55%
More